Trypanosoma cruzi Reactivation After Chimeric Antigen Receptor T-Cell Therapy

被引:0
|
作者
Alahmdi, Bayan [1 ]
Kaur, Avneet [2 ]
Jacobs, Samantha E. [3 ]
Sullivan, Timothy [3 ]
Barghash, Maya [4 ]
Taimur, Sarah [3 ]
机构
[1] King Abdulaziz Univ, Dept Med, Div Infect Dis, Jeddah, Saudi Arabia
[2] City Hope Natl Med Ctr, Dept Med, Div Infect Dis, Duarte, CA USA
[3] Icahn Sch Med Mt Sinai, Div Infect Dis, 1 Gustave L Levy Pl, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Div Cardiol, New York, NY 10029 USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 01期
关键词
chimeric antigen receptor T-cell therapy; diffuse large B-cell lymphoma; hematopoietic cell transplant; Trypanosoma cruzi; CHAGAS-DISEASE; INFECTIOUS COMPLICATIONS; BENZNIDAZOLE; PATIENT;
D O I
10.1093/ofid/ofad698
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
https://tidbitapp.io/tidbits/trypanosoma-cruzi-reactivation-post-chimeric-antigen-receptor-t-cell-therapy/update
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Disseminated toxoplasmosis and haemophagocytic lymphohistiocytosis following chimeric antigen receptor T-cell therapy
    Kator, Sarah
    Zurko, Jessica
    Webb, Brandon J.
    Balatico, Michael A.
    Clayton, Frederic
    Palmer, Cheryl A.
    Konopa, Kelly
    Motyckova, Gabriela
    Ford, Clyde D.
    Ostronoff, Fabiana
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (01) : E4 - E6
  • [22] Cytomegalovirus infection in chimeric antigen receptor T-cell recipients
    Abreu, Michelly
    Varghese, Jaimole
    Santiago, Minifrida
    Ow, Karla
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2023, 35 (11) : 747 - 750
  • [23] Pyoderma Gangrenosum Secondary to Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma
    Mager, Layna
    Mcfeeters, Jacob
    Plaza, Jose A.
    Dulmage, Brittany
    Kaffenberger, Benjamin H.
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2025, 37 (01): : 5 - 7
  • [24] The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy
    Jamal, Faizi A.
    Khaled, Samer K.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (02) : 130 - 132
  • [25] The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy
    Faizi A. Jamal
    Samer K. Khaled
    Current Hematologic Malignancy Reports, 2020, 15 : 130 - 132
  • [26] Chimeric antigen receptor T-cell therapy: Foundational science and clinical knowledge for pharmacy practice
    Dushenkov, Anna
    Jungsuwadee, Paiboon
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (05) : 1217 - 1225
  • [27] Patients' experience with chimeric antigen receptor T-cell therapy for DLBCL in China: a qualitative study
    Mao, Yiwen
    Huang, Lihong
    Ruan, Haitao
    Guo, Yue
    Ni, Sha
    Ling, Yuying
    SUPPORTIVE CARE IN CANCER, 2023, 31 (05)
  • [28] Patients’ experience with chimeric antigen receptor T-cell therapy for DLBCL in China: a qualitative study
    Yiwen Mao
    Lihong Huang
    Haitao Ruan
    Yue Guo
    Sha Ni
    Yuying Ling
    Supportive Care in Cancer, 2023, 31
  • [29] Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma
    Zhou, Dian
    Wang, Ying
    Cheng, Hai
    Zhu, Lili
    Chen, Wei
    Li, Hujun
    Zhang, Xiaotian
    Xia, Jieyun
    Qi, Yuekun
    Ma, Sha
    Zhu, Feng
    Yan, Zhiling
    Qi, Kunming
    Sang, Wei
    Sun, Haiying
    Li, Depeng
    Cao, Jiang
    Li, Zhenyu
    Xu, Kailin
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (02) : 179 - 185
  • [30] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
    Yin, Zixun
    Zhang, Ya
    Wang, Xin
    BIOMARKER RESEARCH, 2021, 9 (01)